Načítá se...
Novel Immunotherapies for Multiple Myeloma
PURPOSE OF REVIEW: The treatment landscape of multiple myeloma is rapidly changing; however, despite improvement in patients’ survival, it still remains a largely incurable disease. One hallmark of myeloma is substantial immune dysfunction leading to an increased infection rate and the inability of...
Uloženo v:
| Vydáno v: | Curr Hematol Malig Rep |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5693669/ https://ncbi.nlm.nih.gov/pubmed/28819882 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-017-0397-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|